Literature DB >> 15934115

Activation of the endoplasmic reticulum stress response in autoimmune myositis: potential role in muscle fiber damage and dysfunction.

Kanneboyina Nagaraju1, Livia Casciola-Rosen, Ingrid Lundberg, Rashmi Rawat, Shawna Cutting, Rachana Thapliyal, Jason Chang, Sunita Dwivedi, Megan Mitsak, Yi-Wen Chen, Paul Plotz, Antony Rosen, Eric Hoffman, Nina Raben.   

Abstract

OBJECTIVE: The etiology and pathogenesis of human inflammatory myopathies remain unclear. Findings of several studies suggest that the degree of inflammation does not correlate consistently with the severity of clinical disease or of structural changes in the muscle fibers, indicating that nonimmune pathways may contribute to the pathogenesis of myositis. This study was undertaken to investigate these pathways in myositis patients and in a class I major histocompatibility complex (MHC)-transgenic mouse model of myositis.
METHODS: We examined muscle tissue from human myositis patients and from class I MHC-transgenic mice for nonimmune pathways, using biochemical, immunohistochemical, and gene expression profiling assays.
RESULTS: Up-regulation of class I MHC in skeletal muscle fibers was an early and consistent feature of human inflammatory myopathies. Class I MHC staining in muscle fibers of myositis patients showed both cell surface and a reticular pattern of internal reactivity. The pathways of endoplasmic reticulum (ER) stress response, the unfolded protein response (glucose-regulated protein 78 pathway), and the ER overload response (NF-kappaB pathway) were significantly activated in muscle tissue of human myositis patients and in the mouse model. Ectopic expression of wild-type mouse class I MHC (H-2K(b)) but not degradable glycosylation mutants of H-2K(b) induced ER stress response in C(2)C(12) skeletal muscle cells.
CONCLUSION: These results indicate that the ER stress response may be a major nonimmune mechanism responsible for skeletal muscle damage and dysfunction in autoimmune myositis. Strategies to interfere with this pathway may have therapeutic value in patients with this disease.

Entities:  

Mesh:

Year:  2005        PMID: 15934115     DOI: 10.1002/art.21103

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN: 0004-3591


  102 in total

Review 1.  Animal models of inflammatory myopathy.

Authors:  Dana P Ascherman
Journal:  Curr Rheumatol Rep       Date:  2012-06       Impact factor: 4.592

2.  Activation of the ubiquitin proteasome pathway in a mouse model of inflammatory myopathy: a potential therapeutic target.

Authors:  Sree Rayavarapu; William Coley; Jack H Van der Meulen; Erdinc Cakir; Kathyayini Tappeta; Travis B Kinder; Blythe C Dillingham; Kristy J Brown; Yetrib Hathout; Kanneboyina Nagaraju
Journal:  Arthritis Rheum       Date:  2013-12

3.  Biochemical and ultrastructural evidence of endoplasmic reticulum stress in LGMD2I.

Authors:  Chiara A Boito; Marina Fanin; Bruno F Gavassini; Giovanna Cenacchi; Corrado Angelini; Elena Pegoraro
Journal:  Virchows Arch       Date:  2007-10-20       Impact factor: 4.064

Review 4.  Advances in the immunobiology and treatment of inflammatory myopathies.

Authors:  Marinos C Dalakas
Journal:  Curr Rheumatol Rep       Date:  2007-08       Impact factor: 4.592

Review 5.  Cellular stress response and innate immune signaling: integrating pathways in host defense and inflammation.

Authors:  Sujatha Muralidharan; Pranoti Mandrekar
Journal:  J Leukoc Biol       Date:  2013-08-29       Impact factor: 4.962

Review 6.  Dermatomyositis.

Authors:  M S Krathen; D Fiorentino; V P Werth
Journal:  Curr Dir Autoimmun       Date:  2008

7.  The inflammatory milieu in idiopathic inflammatory myositis.

Authors:  Ann M Reed; Floranne Ernste
Journal:  Curr Rheumatol Rep       Date:  2009-08       Impact factor: 4.592

8.  Juvenile dermatomyositis: new insights and new treatment strategies.

Authors:  Neil Martin; Charles K Li; Lucy R Wedderburn
Journal:  Ther Adv Musculoskelet Dis       Date:  2012-02       Impact factor: 5.346

9.  Deciphering the clinical presentations, pathogenesis, and treatment of the idiopathic inflammatory myopathies.

Authors:  Lisa G Rider; Frederick W Miller
Journal:  JAMA       Date:  2011-01-12       Impact factor: 56.272

10.  Sarcolipin expression is repressed by endoplasmic reticulum stress in C2C12 myotubes.

Authors:  Nobuhiko Takahashi; Atsushi P Kimura; Sumiyoshi Naito; Mika Yoshida; Osamu Kumano; Takeshi Suzuki; Satoshi Itaya; Mitsuru Moriya; Masahiro Tsuji; Masahiro Ieko
Journal:  J Physiol Biochem       Date:  2017-07-13       Impact factor: 4.158

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.